In an attempt to purify these groups, samples that were misclassified were excluded from further analysis, leaving only 23 familial (13 BRCA1, 10 BRCA2) and 14 sporadic ovarian tumour samples. This evidence concerns the gene BRCA2 and ovarian neoplasm.